Cargando…
New treatment options in allergic rhinitis: patient considerations and the role of ciclesonide
Allergic rhinitis (AR) is a chronic inflammatory respiratory disease affecting 5%–50% of the worldwide population and its prevalence is increasing (Herman 2007). In addition, AR is associated with asthma and other co-morbidities such as conjunctivitis and sinusitis. The main symptoms are nasal conge...
Autores principales: | Braido, F, Lagasio, C, Piroddi, IMG, Baiardini, I, Canonica, GW |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2504079/ https://www.ncbi.nlm.nih.gov/pubmed/18728855 |
Ejemplares similares
-
Intranasal ciclesonide for allergic rhinitis
por: Williams, Ben, et al.
Publicado: (2008) -
Comparison of Intranasal Ciclesonide, Oral Levocetirizine, and Combination Treatment for Allergic Rhinitis
por: Kim, Chang-Hoon, et al.
Publicado: (2015) -
Patients with Asthma and Comorbid Allergic Rhinitis: Is Optimal Quality of Life Achievable in Real Life?
por: Braido, Fulvio, et al.
Publicado: (2012) -
The efficacy and safety of ciclesonide for the treatment of perennial allergic rhinitis: a systematic review and meta-analysis()
por: Yang, Qi, et al.
Publicado: (2018) -
Comparison of sensory attributes and immediate efficacy of intranasal ciclesonide and fluticasone propionate in allergic rhinitis: A randomized controlled trial
por: Varshney, Jitendra, et al.
Publicado: (2012)